Streetbeat News

Regulatory

GMAB

Genmab announced that the U.S. FDA approved EPKINLY for the treatment of adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:54 am

ABBV

AbbVie announced that the U.S. FDA has approved EPKINLY as the first and only T-cell engaging bispecific antibody administered subcutaneously for the treatment of adults with relapsed or refractory follicular lymphoma.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:50 am

NVX

NOVONIX Limited announced it has been granted a patent for its proprietary all-dry, zero-waste cathode synthesis technology in Japan. This development could enhance NOVONIX's competitive edge in the battery materials market.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:46 am

BTCUSD

ETHUSD

IDCBF

Indonesia has experienced a significant cyberattack by the LockBit ransomware gang, affecting over 40 government entities, including major airports and immigration services. The attackers demanded an $8 million ransom in Bitcoin and Ethereum, which the government refused to pay. Efforts are ongoing to restore data at affected agencies.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 5:25 am

BA

SPR

Boeing has refuted claims that NASA astronauts are stranded on its Starliner spacecraft, despite a delayed return from the ISS. The delay comes amid ongoing safety controversies for Boeing, including scrutiny over its 737 Max aircraft. Boeing's proposed acquisition of Spirit Aerosystems is seen as a positive move for recovery.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 3:47 am

GBTC

HODL

IBIT

The SEC is expected to approve Ethereum spot ETFs by July 4, following successful Bitcoin spot ETFs. Asset managers like BlackRock, VanEck, and Grayscale are involved. Analysts predict a less impressive launch for Ethereum ETFs due to its smaller market cap and trading volumes.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 3:09 am

AMZN

NVDA

The cryptocurrency market experienced a downturn due to fears of a $240 million Bitcoin sale by the U.S. government. Bitcoin, Ethereum, and Dogecoin all saw declines. Stocks, however, recorded gains, with Amazon and NVIDIA performing well. Analysts provided mixed forecasts for Bitcoin and the altcoin market.

Portfolio Pulse from Aniket Verma

June 27, 2024 | 1:37 am

NVO

Bernie Sanders criticized the high pricing of the diabetes drug Ozempic, manufactured by Novo Nordisk (NYSE:NVO), suggesting that Americans are charged 10-15 times more than people in other countries. Sanders, who chairs the Senate HELP Committee, has previously criticized the drug's pricing and considered holding hearings on the issue. Novo Nordisk's CEO agreed to testify before the Senate after Sanders threatened to subpoena the company. Following Sanders' tweet, Novo Nordisk shares closed 2.2% lower.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 1:14 am

RIGL

Trading for RIGL was halted at 7:50:00 p.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:50 pm

YYAI

Trading for YYAI was halted at 7:50:00 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:50 pm